Pushpa Tandon, Ph.D.

Program Director

Molecular Imaging Branch

Dr. Pushpa Tandon is a Program director in the Molecular Imaging Branch within the Cancer Imaging Program, Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI). She manages projects in the areas related to image guided intervention, nanotechnology, molecular imaging and global health. She is also the Deputy Director for the Quantitative Imaging Network. Before joining NCI, Dr. Tandon served as the Scientific Review Officer at the Center for Scientific Review, NIH. Dr Tandon has a Ph.D in Chemistry from Lucknow University, India, and came to the USA as a Fogarty Fellow to study alterations in G-protein linked second messengers in the brain following exposure to neurotoxicants. Her work was instrumental in the development of federal guidelines for regulation of pesticide exposure in humans. Dr. Tandon then moved to Harvard Medical School to study genetic and neurological aspects of epilepsy and other neurodegenerative disorders in the developing brain. She moved to NIH from “WellStat Therapeutics”, Gaithersburg, MD, where she was a scientist developing therapeutics for neurological disorders. Dr. Tandon has experience in translational and basic research in neuronal development and neurodegeneration, Imaging technologies and global health. Dr Tandon is an elected  member of “Biomedical Engineering Materials and Applications” a long-standing roundtable of the National Academies of Sciences.